Clinical Trials Logo

Organic Cation Transporter 1 clinical trials

View clinical trials related to Organic Cation Transporter 1.

Filter by:
  • None
  • Page 1

NCT ID: NCT03425084 Completed - Morphine Clinical Trials

Genetic Variation in Organic Cation Transport 1 (OCT1) and Its Significance for Morphine Pharmacokinetics

Start date: June 1, 2018
Phase: Phase 1
Study type: Interventional

The main objective of the trial is to investigate the effect of known genetic variants in organic cation transporter 1 (OCT1) on the effect of morphine after major surgery

NCT ID: NCT03335423 Completed - Metformin Clinical Trials

Inter- and Intra-individual Variations in Metformin Pharmacokinetics - The Importance of Genes and Drug Interactions

Start date: March 1, 2018
Phase: Phase 1
Study type: Interventional

The investigators aim to investigate the interindividual variation in metformin AUC in a large cohort of healthy volunteers after a single dose of metformin. Part 1 is driven by the hypothesis that metformin AUC and renal clearance exhibit significant interindividual variation. However this has never been documented in a large cohort of healthy volunteers. The investigators aim to investigate the potential interaction between codeine and metformin in the intestine. The hypothesis underlying part 3 is that the increased risk of early discontinuation of metformin during co-administration with codeine is primarily due to local inhibition of OCT1 via codeine at the intestinal level.